Quantbot Technologies LP acquired a new stake in agilon health, inc. (NYSE:AGL – Free Report) during the first quarter, HoldingsChannel reports. The fund acquired 141,280 shares of the company’s stock, valued at approximately $862,000.
Other institutional investors have also recently bought and sold shares of the company. Capital World Investors lifted its stake in agilon health by 7.4% in the fourth quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock valued at $692,992,000 after buying an additional 3,813,214 shares during the period. Wellington Management Group LLP increased its stake in shares of agilon health by 2.9% in the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock valued at $533,501,000 after acquiring an additional 1,191,253 shares during the last quarter. Vanguard Group Inc. raised its position in shares of agilon health by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 28,576,261 shares of the company’s stock valued at $358,632,000 after acquiring an additional 220,986 shares during the period. Capital International Investors boosted its stake in agilon health by 16.2% during the 4th quarter. Capital International Investors now owns 10,934,636 shares of the company’s stock worth $137,230,000 after acquiring an additional 1,521,995 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in agilon health by 46.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock valued at $127,256,000 after purchasing an additional 3,195,087 shares in the last quarter.
Analyst Ratings Changes
A number of research analysts have issued reports on AGL shares. Baird R W raised agilon health to a “hold” rating in a research note on Thursday, May 30th. Robert W. Baird began coverage on agilon health in a research note on Thursday, May 30th. They set a “neutral” rating and a $6.00 target price for the company. Citigroup started coverage on shares of agilon health in a research note on Monday, April 22nd. They issued a “neutral” rating and a $6.00 price target on the stock. Evercore ISI raised their price objective on shares of agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a report on Tuesday, July 9th. Finally, Stifel Nicolaus lowered their target price on agilon health from $8.00 to $7.00 and set a “hold” rating for the company in a report on Wednesday, May 1st. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $9.10.
agilon health Trading Up 2.3 %
Shares of agilon health stock opened at $6.29 on Monday. The firm’s 50 day moving average is $6.08 and its 200 day moving average is $6.31. The firm has a market capitalization of $2.59 billion, a PE ratio of -8.99 and a beta of 0.60. agilon health, inc. has a 1 year low of $4.41 and a 1 year high of $21.52. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.04.
agilon health (NYSE:AGL – Get Free Report) last posted its earnings results on Tuesday, May 7th. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.03. agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.62 billion. Equities research analysts forecast that agilon health, inc. will post -0.34 earnings per share for the current fiscal year.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
- Five stocks we like better than agilon health
- Earnings Per Share Calculator: How to Calculate EPS
- Positive News is Driving This Cancer Drug Maker’s Stock Higher
- Investing in Travel Stocks Benefits
- Top 3 Defense Stocks That Should Be on Your Radar
- Overbought Stocks Explained: Should You Trade Them?
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGL – Free Report).
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.